tissue transglutaminase and deamidated gliadin peptidetissue transglutaminase and deamidated gliadin peptide gliadin - Celiac disease deamidated gliadin peptides Understanding Tissue Transglutaminase and Deamidated Gliadin Peptide Antibodies in Celiac Disease Diagnosis

Tissue transglutaminaseIgA U/mL The intricate relationship between tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP) plays a pivotal role in the immunological response observed in individuals with celiac disease. These two components are central to understanding the diagnostic markers used to identify this autoimmune disorder. As research has evolved, the combined use of tissue transglutaminase and deamidated gliadin peptide antibodies has become a cornerstone for accurate celiac diagnosis, offering a more comprehensive picture than relying on a single marker.

The Role of Gliadin and Tissue Transglutaminase

Gliadin, a protein found in gluten — present in wheat, barley, and rye — is a primary trigger for the autoimmune reaction in celiac disease. In the intestinal lining of susceptible individuals, an enzyme known as tissue transglutaminase (TG2) catalyzes the modification of gliadin through a process called deamidation. This enzymatic action transforms gliadin into deamidated gliadin peptides. This modification is crucial because it alters the overall structure of gliadin, making it a more potent autoantigen. The immune system then mistakenly identifies these deamidated gliadin peptides as foreign invaders, initiating an inflammatory cascade.

Antibody Detection: Key Diagnostic Indicators

The body's immune response to these altered gluten peptides results in the production of specific autoantibodies.作者：D Agardh·2007·被引用次数：141—Background & Aims: Children with celiac disease have antibodies againstgliadin,tissue transglutaminase(tTG), or both antigens. Two of the most significant are:

* Tissue Transglutaminase (IgA) (tTG-IgA) antibody: This antibody targets the enzyme tissue transglutaminase itself, as it becomes an autoantigen in the context of celiac disease. The tTG-IgA test is highly specific for celiac disease and is often used as an initial screening toolCeliac Disease Screening. Elevated levels of tissue transglutaminase IgA are strong indicators of the condition.Positive Deamidated Gliadin Peptide Antibodies and Negative ...

* Deamidated Gliadin Peptide Antibodies (DGP): These antibodies are directed against the modified deamidated gliadin peptides. Both immunoglobulin A (IgA) and immunoglobulin G (IgG) forms of these antibodies can be detected作者：EV Marietta·2009·被引用次数：38—DGP and tTG are terms that refer todeamidated gliadin peptidesandtissue transglutaminase, respectively. Also, gluten free diet (GFD) and GCD .... The deamidated gliadin peptide IgG test can be particularly useful for individuals who have an IgA deficiency, a condition more common in those with celiac disease. Research indicates that deamidated gliadin peptides are efficient antigens in diagnostic tests for celiac disease, and their detection offers valuable insights.

Synergistic Power of Combined Testing

While both tTG-IgA and deamidated gliadin peptide (DGP) antibody tests are valuable independently, their combined use often provides superior diagnostic accuracy. Studies, such as those comparing tissue transglutaminase-IgA and deamidated gliadin peptide-IgG, highlight the benefits. For instance, some individuals may present with deamidated gliadin peptide (DGP) antibodies that show positive results while simultaneously having negative results for tissue transglutaminase IgA. This scenario underscores the importance of considering both markers, as relying solely on one might lead to a missed diagnosis.

The pooled sensitivities for the deamidated gliadin peptides antibody and tissue transglutaminase antibody tests, as reported in meta-analyses, demonstrate their high performance. While tissue transglutaminase antibody tests show a high sensitivity of approximately 93.Deamidated Gliadin Antibodies: Do They Add to Tissue ...0%, deamidated gliadin peptides antibody tests are also highly effective, with a sensitivity around 87.作者：U Volta·2008·被引用次数：174—The combined use oftissue transglutaminase and deamidated gliadin peptide antibodiesseems to be a very useful tool for celiac disease diagnosis. Moreover ...8%. This indicates that including both tests in the diagnostic workup can capture a broader range of positive cases. However, it's also noted that deamidated gliadin peptides result in a higher false-positive rate in some contexts, emphasizing the need for careful interpretation by healthcare professionals.

Beyond IgA: Considering IgG and Other Factors

While the IgA form of tissue transglutaminase is a primary marker, the role of IgG antibodies is also recognized. For example, the deamidated gliadin peptide IgG antibody test is crucial for diagnosing celiac disease in individuals with IgA deficiency作者：NR LEWIS·2010·被引用次数：314—The pooled sensitivities for thedeamidated gliadin peptidesantibody andtissue transglutaminaseantibody tests were 87.8% (95% CI, 85.6–. 89.9) and 93.0 .... In some research, authors have explored the utility of both IgA tissue transglutaminase and IgG- deamidated gliadin peptide antibodies, suggesting their combined assessment offers accurate celiac disease diagnosis without necessarily requiring further invasive procedures like endoscopy in all cases.

Expert Interpretation and Next Steps

The detection of tissue transglutaminase and deamidated gliadin peptide antibodies is a critical step in the diagnostic process for celiac disease.Antibodies Against Synthetic Deamidated Gliadin Peptides ... However, it is essential that these tests are interpreted by experienced healthcare providers.Hi everyone …wanted to ask you about handling dry cat food I give my 4 cats every day that has gluten in it, and could it cause a reaction? Just ... The deamidated gliadin meaning refers to the enzymatic modification of gliadin, and understanding these physiological processes is key. Depending on the results, a healthcare professional will guide further investigations, which may include genetic testing or an intestinal biopsy, to confirm the diagnosis. Ultimately, a gluten-free diet (GFD) is the primary treatment for celiac disease, and early and accurate diagnosis facilitated by antibody testing is paramount for managing the condition and preventing long-term health complicationsIn particular,deamidated gliadin peptides result in a higher false-positive ratethat can lead to further unnecessary testing and/or endoscopy. Sponsoring .... The continuous research into deamidated gliadin antibodies and their relationship with traditional markers like tissue transglutaminase promises further refinement in the diagnostic landscape of celiac disease.作者：NR LEWIS·2010·被引用次数：314—The pooled sensitivities for thedeamidated gliadin peptidesantibody andtissue transglutaminaseantibody tests were 87.8% (95% CI, 85.6–. 89.9) and 93.0 ...